Alexander Cools — Dutch neuroscientist and pioneer in behavioral pharmacology

Overview of Alexander R. "Lex" Cools (1941–2013), his career at Radboud, contributions to dopamine receptor theory and basal ganglia research, and his role in European behavioural pharmacology.

Alexander Rudolf "Lex" Cools (1941–2013) was a Dutch neuroscientist whose work helped shape modern ideas about how neurotransmitters control action and motivation. Born in The Hague and later based in Nijmegen, Cools combined behavioral experiments with pharmacology to probe the brain mechanisms underlying movement, learning and psychiatric symptoms.

Education and academic career

Cools earned his Doctor of Philosophy degree in 1973 from Radboud University Nijmegen. He remained at Radboud for most of his career and served as a professor there from 1985 until his retirement in 2006. During these years he supervised students and postdoctoral researchers and built a program focused on experimental approaches to the pharmacology of behavior.

Scientific contributions

Working at the intersection of behavior and neurochemistry, Cools was among the earliest scientists to argue that dopamine does not act through a single uniform receptor mechanism. In 1976 he proposed the existence of distinct types of dopamine receptors — an idea that anticipated later molecular and pharmacological findings demonstrating multiple receptor subfamilies. His cautious, evidence‑driven approach helped shift research from broad behavioral descriptions to mechanistic studies of receptor subtypes and their functional consequences.

Cools also made substantial contributions to the study of the basal ganglia, a group of brain structures central to motor control, habit formation and certain aspects of decision making. By combining pharmacological manipulations with behavioral assays in animals, he and his collaborators explored how changes in dopaminergic signaling could alter movement, reinforcement learning and responses to drugs used in neurology and psychiatry.

Legacy and professional activities

Beyond his laboratory research, Cools was active in shaping the field of behavioural pharmacology in Europe. He was one of the founders of the European Behavioural Pharmacology Society and served as its second president. The society honored him with its Distinguished Achievement Award in 2003. Following his death in 2013, the journal Behavioural Pharmacology published a special issue dedicated to his memory, reflecting his influence on colleagues and trainees.

Research themes and impact

Dopamine receptor diversity: early advocacy for multiple receptor classes that later guided receptor‑focused pharmacology.
Behavioral pharmacology methods: integration of drug treatments with task‑based measures of learning and motor function.
Basal ganglia function: experimental work linking neurotransmitter systems to the control of action and habit.
Community leadership: organizing and mentoring within European behavioural pharmacology networks.

Cools' career illustrates how careful behavioral experiments combined with pharmacological tools can reveal the organization of brain systems and inform clinical approaches to disorders such as Parkinson's disease and psychiatric conditions where dopamine signaling is disrupted. His proposals about receptor diversity and his empirical studies of the basal ganglia remain part of the foundation for current research into the neurochemical basis of behavior.

Further reading and archival material about his life and work can be located through institutional records and collected volumes devoted to behavioural pharmacology and neuroscience history. For institutional and biographical references see university archives and society publications.